Annual Long Term Debt
$206.41 M
-$16.60 M-7.44%
December 31, 2024
Summary
- As of February 27, 2025, CRSP annual long term debt is $206.41 million, with the most recent change of -$16.60 million (-7.44%) on December 31, 2024.
- During the last 3 years, CRSP annual long term debt has fallen by -$6.47 million (-3.04%).
- CRSP annual long term debt is now -9.54% below its all-time high of $228.18 million, reached on December 31, 2022.
Performance
CRSP Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$206.41 M
-$4.26 M-2.02%
December 31, 2024
Summary
- As of February 27, 2025, CRSP quarterly long term debt is $206.41 million, with the most recent change of -$4.26 million (-2.02%) on December 31, 2024.
- Over the past year, CRSP quarterly long term debt has dropped by -$8.45 million (-3.93%).
- CRSP quarterly long term debt is now -11.85% below its all-time high of $234.16 million, reached on June 30, 2022.
Performance
CRSP Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
CRSP Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.4% | -3.9% |
| 3 y3 years | -3.0% | -3.9% |
| 5 y5 years | +368.6% | -3.9% |
CRSP Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.5% | at low | -11.8% | at low |
| 5 y | 5-year | -9.5% | +368.6% | -11.8% | +435.1% |
| alltime | all time | -9.5% | -100.0% | -11.8% | -100.0% |
CRISPR Therapeutics AG Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $206.41 M(-7.4%) | $206.41 M(-2.0%) |
| Sep 2024 | - | $210.66 M(-2.0%) |
| Jun 2024 | - | $214.85 M(-1.9%) |
| Mar 2024 | - | $218.94 M(-1.8%) |
| Dec 2023 | $223.01 M(-2.3%) | $223.01 M(-1.6%) |
| Sep 2023 | - | $226.59 M(-1.6%) |
| Jun 2023 | - | $230.34 M(+2.6%) |
| Mar 2023 | - | $224.55 M(-1.6%) |
| Dec 2022 | $228.18 M(+7.2%) | $228.18 M(-1.2%) |
| Sep 2022 | - | $230.90 M(-1.4%) |
| Jun 2022 | - | $234.16 M(+2.7%) |
| Mar 2022 | - | $227.90 M(+7.1%) |
| Dec 2021 | $212.87 M | $212.87 M(+10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $192.73 M(+9.9%) |
| Jun 2021 | - | $175.33 M(+254.9%) |
| Mar 2021 | - | $49.41 M(-1.3%) |
| Dec 2020 | $50.07 M(+13.7%) | $50.07 M(+29.8%) |
| Sep 2020 | - | $38.57 M(-4.3%) |
| Jun 2020 | - | $40.32 M(-4.9%) |
| Mar 2020 | - | $42.39 M(-3.8%) |
| Dec 2019 | $44.05 M(>+9900.0%) | $44.05 M(+19.6%) |
| Sep 2019 | - | $36.83 M(-1.0%) |
| Jun 2019 | - | $37.20 M(+17.2%) |
| Mar 2019 | - | $31.73 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2015 | $38.34 M | $38.34 M |
FAQ
- What is CRISPR Therapeutics AG annual long term debt?
- What is the all time high annual long term debt for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual long term debt year-on-year change?
- What is CRISPR Therapeutics AG quarterly long term debt?
- What is the all time high quarterly long term debt for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly long term debt year-on-year change?
What is CRISPR Therapeutics AG annual long term debt?
The current annual long term debt of CRSP is $206.41 M
What is the all time high annual long term debt for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual long term debt is $228.18 M
What is CRISPR Therapeutics AG annual long term debt year-on-year change?
Over the past year, CRSP annual long term debt has changed by -$16.60 M (-7.44%)
What is CRISPR Therapeutics AG quarterly long term debt?
The current quarterly long term debt of CRSP is $206.41 M
What is the all time high quarterly long term debt for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly long term debt is $234.16 M
What is CRISPR Therapeutics AG quarterly long term debt year-on-year change?
Over the past year, CRSP quarterly long term debt has changed by -$8.45 M (-3.93%)